We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$69.1B
$69.1B $21.64 0.23%
TEVA icon
2
Teva Pharmaceutical Industries
TEVA
$49.7B
$49.7B $42.63 0.14%
HLN icon
3
Haleon
HLN
$39.8B
$39.8B $9.06 1.52%
ZTS icon
4
Zoetis
ZTS
$33.9B
$33.9B $83.47 1.09%
UTHR icon
5
United Therapeutics
UTHR
$24.9B
$24.9B $583.99 0.66%
VTRS icon
6
Viatris
VTRS
$23.4B
$23.4B $20.44 1.45%
NBIX icon
7
Neurocrine Biosciences
NBIX
$16.8B
$16.8B $165.94 0.38%
ELAN icon
8
Elanco Animal Health
ELAN
$12.9B
$12.9B $25.85 2.12%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$12.3B
$12.3B $14.80 0.68%
ALKS icon
10
Alkermes
ALKS
$7.64B
$7.64B $45.46 2.3%
KNSA icon
11
Kiniksa Pharmaceuticals
KNSA
$7.47B
$7.47B $95.12 0.94%
AMRX icon
12
Amneal Pharmaceuticals
AMRX
$7.36B
$7.36B $21.13 0.47%
LNTH icon
13
Lantheus
LNTH
$6.66B
$6.66B $101.82 0.1%
SUPN icon
14
Supernus
SUPN
$6.04B
$6.04B $29.06 0.8%
LQDA icon
15
Liquidia
LQDA
$5.12B
$5.12B $56.83 0.82%
HIMS icon
16
Hims & Hers Health
HIMS
$4.11B
$4.11B $17.55 5.44%
AMLX icon
17
Amylyx Pharmaceuticals
AMLX
$3.54B
$3.54B $27.52 1.01%
BHC icon
18
Bausch Health
BHC
$3.17B
$3.17B $8.47 0.59%
XERS icon
19
Xeris Biopharma Holdings
XERS
$3.07B
$3.07B $16.79 0.54%
HCM icon
20
HUTCHMED
HCM
$2.5B
$2.5B $14.41 2.17%
PBH icon
21
Prestige Consumer Healthcare
PBH
$2.29B
$2.29B $48.21 0.44%
RGC icon
22
Regencell Bioscience
RGC
$2.23B
$2.23B $4.50 4.66%
PRGO icon
23
Perrigo
PRGO
$2.19B
$2.19B $15.77 2.53%
BCRX icon
24
BioCryst Pharmaceuticals
BCRX
$1.93B
$1.93B $7.51 0.81%
ETON icon
25
Eton Pharmaceutcials
ETON
$1.83B
$1.83B $63.56 0.5%

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 79 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $369B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $69.1B, Teva Pharmaceutical Industries (TEVA) at $49.7B and Haleon (HLN) at $39.8B.

Among institutional investors, Eton Pharmaceutcials (ETON) drew the most net new fund positions in Q3 2026: 76 funds opened new positions, taking total fund holders up 50 (30%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.